PGF and breast carcinoma: Using prospectively collected, pre-diagnostic serum samples from the screening arm of the prostate, lung, colon, and ovary cancer trial (PLCO) [18], we assessed whether healthy women with high levels of VEGF and PlGF along with low circulating sFlt-1 would be at elevated risk of breast cancer.